of the Insights in Hematology

2022 Conference

Gabriel Ghiaur, M.D., Ph.D.

Dr. Ghiaur, a member of the Johns Hopkins Kimmel Cancer Center, is a physician-scientist whose primary interest is normal and malignant hematopoiesis, especially the role of the microenvironment in stem cell biology. His research has translational potential in stem cell therapeutics, as well as acute leukemia.


Alina Tănase, M.D.

Dr. Alina Tanase is head of the Bone marrow Transplantation Unit at the Fundeni Clinical Institute with expertise in hematology, pediatrics and clinical immunolgy. She was the manager of a postdoctoral research scholarship in a POSDRU 2010-2013 grant entitled “Supporting research by forming highly trained specialists during postdoctoral research”. Dr. Alina Tanase has published several internationally peer-reviewed papers in important journals such as Leukemia, the Lancet Oncology or Transplantation Proceedings.


Anca Colita, M.D.

Catherine Bollard, MBChB, MD, FRACP, FRCPA

Bosworth Chair for Cancer Biology
Director, Center for Cancer and Immunology Research
Professor of Pediatrics and of Microbiology, Immunology and Tropical Medicine
Director, Program for Cell Enhancement and Technologies for Immunotherapy
Children’s National Health System
The George Washington University School of Medicine and Health Sciences
Washington, DC

Dr. Bollard received her medical degree at the University of Otago in Dunedin, New Zealand. She is board certified both in pediatrics and hematology. She worked in New Zealand and London, England, before moving to Houston, Texas, in 2000 where she was a Professor of Pediatrics, Medicine, and Immunology at Baylor College of Medicine (BCM) and the Director of the Texas Children’s Cancer and Hematology Center Pediatric Lymphoma Program. In August 2013, she was recruited to Washington, DC, to join Children’s National Health System and The George Washington University School of Medicine and Health Sciences. She is currently the Bosworth Chair for Cancer Biology, the Director of the Center for Cancer and Immunology Research, and the Director of the Program for Cell Enhancement and Technologies for Immunotherapy (CETI) at Children’s National Health System. She is a Professor of Pediatrics and of Microbiology, Immunology, and Tropical Medicine at The George Washington University and the Associate Center Director for Translational Research and Innovation at the GW Cancer Center. Dr. Bollard is a member of the American Society for Clinical Investigation (ASCI), is a past president of the International Society for Cellular Therapy (ISCT), and is the current President of the Foundation for the Accreditation of Cellular Therapy (FACT). She was a member of the Cellular, Tissues, and Gene Therapies Advisory Committee of the Food and Drug Administration (FDA) from 2015 to 2019 and in 2019 she became a member of the Frederick National Laboratory Advisory Committee (FNLAC) for the NIH and an ad hoc member of the Pediatric Oncologic Drugs Advisory Committee (ODAC) for the FDA. She was an associate editor for the journal Blood from 2014-2021 and is currently Editor in Chief of Blood Advances. She has >200 peer reviewed publications and has been independently NIH funded for over a decade. Her bench and translational research focuses on improving outcomes for patients after hematopoietic stem cell transplantation and on the development of novel cell therapies for cancer and virus-associated diseases.


Ciprian Tomuleasa, M.D.

Dr. Ciprian Tomuleasa is the Congress Director of Insights in Hematology Conference. Dr. Tomuleasa is a young physician-scientiest that is currently affiliated with the Ion Chiricuță Clinical Cancer Center and Iuliu Hațieganu University of Medicine and Pharmacy Cluj Napoca, Romania. He did part of his training as a postdoctoral fellow at the Johns Hopkins University in the department of medicine, division of GI, and his transplant rotations with Dr. Ciurea at the University of Texas MD Anderson Cancer Center. His current research regards the molecular mechanism of haematological malignancies and the translation of his knowledge in the clinical setting. He published 85 papers, was cited 600 times and has a Hirsch index of 16.


Delia Dima, M.D.

Dr. Delia Dima is a senior hematologist at the Ion Chiricuta Oncology Institute and will talk about the clinical nursing approach for the haemophilia patient, as a symposium organized on behalf of the Romanian Society of Hematology for Romania 3 Project – Strenghten haemophilia care in the north and establish a national registry in Romania, grant awarded for 2020 – 2021 by the Novo Nordisk Haemophilia Foundation.



Johnny Mahlangu, M.D.

Jon Thor Bergthorsson, M.D.

Associate professor,
School of Health Sciences,
University of Iceland,

Director of FACS unit,
Department of Laboratory Hematology,
Landspitali-University Hospital


Jonathan Fromm, M.D.

Liran Shlush, M.D., Ph.D.

Lukasz Gondek, M.D.

Assistant Professor of Oncology, Johns Hopkins University


Massimo Federico, M.D., Ph.D.

Professor Federico graduated from medical school at Catholic University of Rome and then completed a 3-year hematology post-graduate course at the University of Modena and, after it undertook a 5-year program on internal medicine at the University of Pavia. Professor Federico is board-certified in hematology and internal medicine. After working in the department of internal medicine in Modena, in 1985 he moved to the new area of medical oncology.
Since 1998, Massimo Federico is Professor of Medical Oncology at the University of Modena and Reggio Emilia, Modena, Italy, as well as President of the Angela Serra Association for Cancer Research. From 2011-2013 he was President of Fondazione Italiana Linfomi (FIL). From 2013-2016 chaired the Advisory Bard of the Lymphoma Hub a global online platform whose vision is to provide up-to-date, practical, clinical advice to community hem-oncologists, hematologists and oncologists seeking treatment and management options for Lymphoma and CLL (Lymphomahub.com). He is at present president of the AIBE (Associazione Italo Brasiliana di Ematologia). Currently, Professor Federico is Head of the Oncology Department at Città di Lecce Hospital, Care & Research, in Lecce.


Mihnea Zdrenghea, M.D., Ph.D.

Dr. Mihnea Zdrenghea is one of the most appreciated hematologists in Romania, with a significant backround in both medical and clinical research. Dr. Zdrenghea has completed his PhD in tumor immunology and is the author of more than 20 scientific papers, as well as an author to 6 books. He is an attending physician in hematology at the Oncology Institute “Prof. Dr. Ion Chiricuta” in Cluj-Napoca. The skills and qualification of him as a department leader reflect on the entire research team and it is apparent the the collaboration with partner investigators can be accomplished. The publications and extensive experience in cancer biology research, proven by his ongoing projects and previous results, recommend Dr. Zdrenghea for capably managing a professional team of researchers that have the potential of bringing new innovative results


Pierre FENAUX, M.D., Ph.D.

Renata Zahu, M.D.

I am a Radiation Oncologist and also University Assistant at the UMF Cluj, Radiotherapy Department
I am also Medical Director of Amethyst Radiotherapy Center Cluj


Stefan Ciurea, M.D.

Professor of Clinical Medicine
Director, Hematopoietic Stem Cell Transplantation and Cellular Therapy Program
Division of Hematology/Oncology, Department of Medicine
Chao Family Comprehensive Cancer Center
University of California, Irvine | UCI Health


Stephanie Halene, M.D.

Arthur H. and Isabel Bunker Associate Professor of Hematology
Chief, Section of Hematology
Department of Internal Medicine and Yale Cancer Center
Yale University School of Medicine